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Dear Editor,
Lupus panniculitis or lupus profundus is a rare 
inflammatory complication found in patients with 
systemic lupus erythematosus (SLE), or discoid lupus 
erythematosus (DLE) (1). When the breast is involved, 
the term lupus mastitis (LM) is used. This disease in-
volving the breast is rare, and the lesions may pre-
cede, coincide with, or occur later than the onset of 
other lupus lesions. Tissue biopsy is required to con-
firm the suspected diagnoses of LM. We report a case 
of a patient with lupus mastitis due to the important 
differential diagnosis.
A 60-year-old woman presented with a painful 
nodular lesion in her left breast that had appeared 
15 days ago (Figure 1, a). She had been previously 
diagnosed with discoid lupus erythematosus 3 years 
ago. Physical examination revealed a deep and firm 
erythematous subcutaneous nodule without overly-
ing skin involvement in the lower-central portion of 
the left breast. Laboratory findings were positive for 
antinuclear antibodies (1:80) and double-stranded 
deoxynucleic acid antibodies (1:10). Mammography 
and ultrasounds showed an area of increased density 
and irregular breast tissue along with an important 
thickening of the overlying skin (Figure 1, b). 
On suspicion of malignancy, a needle biopsy of 
the breast lesion was performed and showed vacu-
olar alteration and lymphocytic infiltrate in the basal 
layer. Subcutaneous fat showed a lobular panniculitis 
with a prominent lymphocytic infiltrate and hyalin-
ization of the fat lobules (hyaline fat necrosis). Direct 
immunofluorescence of the face biopsy revealed IgA, 
IgG, IgM, and C3 granular deposition. Based on these 
results, a diagnosis of lupus mastitis associated with 
DLE was established. Antimalarial therapy resulted 
in complete resolution of the clinical features. Three 
years later, the patient presented with a disfiguring 
atrophy with retraction in the damaged areas of the 
breast (Figure 2).
Lupus mastitis is a very unusual disease that most 
commonly affects middle-aged women. The first case 
of LM was described by Tuffanelli in 1971. The lesions 
usually present following the diagnosis of SLE/DLE; 
however, on rare occasions they may be observed 
earlier (2). 
The histophysiology of this disease remains un-
clear, but the predominant theory suggests an auto-
immune-related etiology. Corroborating evidence for 
this theory includes the finding of immune complex-
es, both at the basement membrane of the dermal-
epidermal junction and in the blood vessels in the 
areas of panniculitis (3).
Figure 1. (a) Nodular lesion in the left breast. (b) Mammog-
raphy: increased density and irregular breast tissue. Figure 2. Disfiguring atrophy with tissue retraction.
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Lupus mastitis may be present in the breast as 
single or multiple subcutaneous nodules that may be 
tender or painful and can progress to chronic ulcers 
over time or resolve, leaving atrophic scars. The overly-
ing skin can be normal, erythematous, poikilodermic 
or ulcerated. When skin changes are prominent, the 
lesion may clinically and radiologically mimic inflam-
matory breast carcinoma. Mammographic and ultra-
sounds findings include an ill-defined breast density 
with or without associated microcalcifications (4). 
Histologically, this disease is characterized by 
lobular lymphocytic panniculitis and predominantly 
involves the fat lobule and the presence of anucleat-
ed adipocytes in a background of a glassy-appearing 
collagenous stroma (hyaline fat necrosis). Fibrinoid 
necrosis of the vessel wall has also been reported, but 
is usually absent (5).
Differential diagnosis of lupus mastitis includes 
inflammatory breast carcinoma, primary medullary 
carcinoma, and other immune-mediated inflamma-
tory conditions such as diabetic mastopathy.
The first line of treatment the use of antimalarial 
drugs such as hydroxychloroquine. Systemic steroids 
and cyclophosphamide have also been used. Surgical 
treatment should be considered only in patients who 
do not respond to management with medications. 
In summary, we reported a case of lupus mastitis 
in a patient with discoid lupus erythematosus. This 
dermatosis should be considered in the differential 
diagnosis of breast lesions in lupus patients, and a 
biopsy of the breast lesion is essential to reject sus-
pected malignancy. If the disease is left untreated, 
unsightly atrophy will appear; it is thus important to 
diagnose early on. The course of the disease tends 
to be chronic with remission and flares, so patients 
should be followed-up regularly due to the risk of re-
currences in the same area or in a different location.
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